HUP0102507A3 - Use of paroxetine in manufacture of a medicament for use in promoting smoking cessation or reduction or preventing smoking - Google Patents
Use of paroxetine in manufacture of a medicament for use in promoting smoking cessation or reduction or preventing smokingInfo
- Publication number
- HUP0102507A3 HUP0102507A3 HU0102507A HUP0102507A HUP0102507A3 HU P0102507 A3 HUP0102507 A3 HU P0102507A3 HU 0102507 A HU0102507 A HU 0102507A HU P0102507 A HUP0102507 A HU P0102507A HU P0102507 A3 HUP0102507 A3 HU P0102507A3
- Authority
- HU
- Hungary
- Prior art keywords
- smoking
- paroxetine
- medicament
- manufacture
- reduction
- Prior art date
Links
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229960002296 paroxetine Drugs 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
- 230000005586 smoking cessation Effects 0.000 title 1
- 230000000391 smoking effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Addiction (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9812941.4A GB9812941D0 (en) | 1998-06-16 | 1998-06-16 | Method of treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0102507A2 HUP0102507A2 (hu) | 2002-05-29 |
HUP0102507A3 true HUP0102507A3 (en) | 2003-12-29 |
Family
ID=10833832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0102507A HUP0102507A3 (en) | 1998-06-16 | 1999-06-16 | Use of paroxetine in manufacture of a medicament for use in promoting smoking cessation or reduction or preventing smoking |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1087766A4 (hu) |
JP (1) | JP2002518330A (hu) |
KR (1) | KR20010052895A (hu) |
CN (1) | CN1305379A (hu) |
AP (1) | AP2000002002A0 (hu) |
AU (1) | AU740749B2 (hu) |
BG (1) | BG105127A (hu) |
BR (1) | BR9911150A (hu) |
CA (1) | CA2335236A1 (hu) |
CZ (1) | CZ20004698A3 (hu) |
EA (1) | EA003584B1 (hu) |
GB (1) | GB9812941D0 (hu) |
HU (1) | HUP0102507A3 (hu) |
IL (1) | IL139943A0 (hu) |
NO (1) | NO20006383D0 (hu) |
NZ (1) | NZ508532A (hu) |
PL (1) | PL345261A1 (hu) |
SK (1) | SK19192000A3 (hu) |
WO (1) | WO1999065491A1 (hu) |
ZA (1) | ZA200007396B (hu) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ523902A (en) * | 2000-08-28 | 2004-05-28 | Synthon Bv | Paroxetine compositions and processes for making the same |
IL162458A0 (en) * | 2001-12-28 | 2005-11-20 | Teva Pharma | A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof |
US20060039975A1 (en) * | 2004-08-20 | 2006-02-23 | Zalman Vilkov | Paroxetine formulations |
FR2926221A1 (fr) * | 2008-01-14 | 2009-07-17 | Tassin Thomas | Compositions permettant la reproduction artificielle des conditions pharmacologiques de la dependance aux drogues addictives telles que opiaces, psychostimulants, tabac et alcool, par la combinaison de nicotine et d'un ligand. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3688827T2 (de) * | 1985-10-25 | 1994-03-31 | Beecham Group Plc | Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel. |
CA2096853A1 (en) * | 1990-11-24 | 1992-05-25 | Anthony Michael Johnson | Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia |
SK283608B6 (sk) * | 1995-02-06 | 2003-10-07 | Smithkline Beecham Plc | Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie |
GB9605828D0 (en) * | 1996-03-20 | 1996-05-22 | Smithkline Beecham Plc | Treatment method |
-
1998
- 1998-06-16 GB GBGB9812941.4A patent/GB9812941D0/en not_active Ceased
-
1999
- 1999-06-16 KR KR1020007014240A patent/KR20010052895A/ko not_active Application Discontinuation
- 1999-06-16 EA EA200100041A patent/EA003584B1/ru not_active IP Right Cessation
- 1999-06-16 IL IL13994399A patent/IL139943A0/xx unknown
- 1999-06-16 JP JP2000554371A patent/JP2002518330A/ja not_active Withdrawn
- 1999-06-16 EP EP99930327A patent/EP1087766A4/en not_active Withdrawn
- 1999-06-16 AU AU46885/99A patent/AU740749B2/en not_active Ceased
- 1999-06-16 AP APAP/P/2000/002002A patent/AP2000002002A0/en unknown
- 1999-06-16 CZ CZ20004698A patent/CZ20004698A3/cs unknown
- 1999-06-16 SK SK1919-2000A patent/SK19192000A3/sk unknown
- 1999-06-16 WO PCT/US1999/013623 patent/WO1999065491A1/en not_active Application Discontinuation
- 1999-06-16 HU HU0102507A patent/HUP0102507A3/hu unknown
- 1999-06-16 CA CA002335236A patent/CA2335236A1/en not_active Abandoned
- 1999-06-16 BR BR9911150-0A patent/BR9911150A/pt not_active Application Discontinuation
- 1999-06-16 PL PL99345261A patent/PL345261A1/xx not_active Application Discontinuation
- 1999-06-16 NZ NZ508532A patent/NZ508532A/en unknown
- 1999-06-16 CN CN99807465A patent/CN1305379A/zh active Pending
-
2000
- 2000-12-12 ZA ZA200007396A patent/ZA200007396B/xx unknown
- 2000-12-14 NO NO20006383A patent/NO20006383D0/no unknown
-
2001
- 2001-01-08 BG BG105127A patent/BG105127A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PL345261A1 (en) | 2001-12-03 |
HUP0102507A2 (hu) | 2002-05-29 |
JP2002518330A (ja) | 2002-06-25 |
ZA200007396B (en) | 2002-02-27 |
SK19192000A3 (sk) | 2001-05-10 |
AP2000002002A0 (en) | 2000-12-31 |
CA2335236A1 (en) | 1999-12-23 |
CN1305379A (zh) | 2001-07-25 |
BR9911150A (pt) | 2001-03-06 |
NO20006383L (no) | 2000-12-14 |
EP1087766A1 (en) | 2001-04-04 |
AU740749B2 (en) | 2001-11-15 |
KR20010052895A (ko) | 2001-06-25 |
NO20006383D0 (no) | 2000-12-14 |
CZ20004698A3 (cs) | 2002-02-13 |
EA003584B1 (ru) | 2003-06-26 |
NZ508532A (en) | 2003-08-29 |
AU4688599A (en) | 2000-01-05 |
EA200100041A1 (ru) | 2001-06-25 |
BG105127A (en) | 2001-11-30 |
EP1087766A4 (en) | 2001-11-21 |
GB9812941D0 (en) | 1998-08-12 |
WO1999065491A1 (en) | 1999-12-23 |
IL139943A0 (en) | 2002-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0104379A3 (en) | New crystalline form of omeprazole and medicament containing it | |
EG22308A (en) | Tobacco treatment | |
HUP0103621A2 (hu) | Fentanilkészítmény akut fájdalom kezelésére | |
HUP0203204A3 (en) | Oral dosage forms | |
IL144637A0 (en) | Diaryl derivatives and their use as medicaments | |
SI1410800T1 (sl) | Uporaba 1-4-(5-cianoindol-3-il)butil-4-(2-karbamoil-benzofuran-5-il)pipearazina in njegovih fiziolosko sprejemljivih soli | |
AU3240402A (en) | Compounds and methods for promoting smoking cessation | |
GB2337200B (en) | Smoking substance for use in therapy | |
IL137937A0 (en) | A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal | |
IL139775A0 (en) | A substituted triazolo-pyridazine derivative and pharmaceutical compositions made therefrom | |
HUP0102507A3 (en) | Use of paroxetine in manufacture of a medicament for use in promoting smoking cessation or reduction or preventing smoking | |
IL137684A0 (en) | Salts of paroxetine | |
IL140385A0 (en) | Salts of paroxetine | |
AU6293101A (en) | Method of promoting smoking cessation | |
HUP0102929A3 (en) | Use of levosimendan in the manufacture of a medicament for the treatment of pulmonary hypertension | |
PL345781A1 (en) | Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain | |
GB9827865D0 (en) | Medicament | |
IL123422A0 (en) | Use of 7alpha-methyl-17alpha-ethynyl-estrane derivatives for the manufacture of a medicament for the prophylaxis or the treatment of atherosclerosis | |
GB9917217D0 (en) | Scratcher | |
GB2364584B (en) | A smoking cessation aid | |
AU141598S (en) | Saliva barrier for smoking utensils | |
AU141597S (en) | Saliva barrier for smoking utensils | |
AU2616899A (en) | Use of phenylthienylmethylene piperidine derivatives in the manufacture of a medicament for the treatment of depression | |
HK1047232A1 (zh) | 口服劑型 | |
ZA994931B (en) | Tipping rail hopper and tip. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |